X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12896) 12896
Publication (526) 526
Book Review (464) 464
Newsletter (62) 62
Conference Proceeding (28) 28
Book Chapter (22) 22
Dissertation (6) 6
Magazine Article (4) 4
Book / eBook (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12073) 12073
guanidines - pharmacology (8234) 8234
animals (7796) 7796
male (4067) 4067
humans (3694) 3694
rats (3470) 3470
female (1967) 1967
biochemistry & molecular biology (1962) 1962
pharmacology & pharmacy (1920) 1920
mice (1668) 1668
kinetics (1546) 1546
guanidine (1449) 1449
in vitro techniques (1247) 1247
enzyme inhibitors - pharmacology (1137) 1137
dose-response relationship, drug (1120) 1120
guanidine - pharmacology (1116) 1116
guanidines - therapeutic use (1045) 1045
guanidines (1006) 1006
time factors (936) 936
rats, sprague-dawley (850) 850
hydrogen-ion concentration (841) 841
adult (771) 771
protein denaturation (747) 747
protein folding (747) 747
structure-activity relationship (747) 747
abridged index medicus (738) 738
chemistry, medicinal (713) 713
circular dichroism (705) 705
nitric oxide synthase - antagonists & inhibitors (703) 703
nitric oxide (681) 681
rats, wistar (681) 681
guanidines - chemistry (656) 656
aminoguanidine (652) 652
cimetidine - pharmacology (643) 643
proteins (624) 624
guanidines - metabolism (600) 600
middle aged (596) 596
cells, cultured (582) 582
protein conformation (575) 575
rabbits (562) 562
guinea pigs (554) 554
dogs (553) 553
blood pressure - drug effects (546) 546
thermodynamics (529) 529
research (528) 528
pinacidil (520) 520
cell line (513) 513
temperature (510) 510
urea - pharmacology (509) 509
immunology (506) 506
models, molecular (506) 506
guanidines - administration & dosage (497) 497
rats, inbred strains (494) 494
cattle (489) 489
expression (480) 480
sulfones - pharmacology (480) 480
guanidines - chemical synthesis (473) 473
protein denaturation - drug effects (468) 468
analysis (466) 466
spectrometry, fluorescence (466) 466
binding sites (450) 450
inhibition (432) 432
cell biology (431) 431
surgery (425) 425
mutation (422) 422
physiology (420) 420
cells (416) 416
biophysics (412) 412
neurosciences (403) 403
sodium-hydrogen exchangers - antagonists & inhibitors (401) 401
protein binding (381) 381
disease models, animal (379) 379
molecular structure (376) 376
molecular sequence data (368) 368
amino acid sequence (367) 367
nitric oxide synthase type ii (364) 364
potassium channels - drug effects (361) 361
rat (360) 360
vasodilator agents - pharmacology (347) 347
transplantation (342) 342
fluorescence (339) 339
chemistry (336) 336
imidazoles - pharmacology (323) 323
nitric-oxide synthase (323) 323
aged (322) 322
protein (313) 313
guanidine - chemistry (312) 312
binding (311) 311
in-vitro (310) 310
nitric oxide - metabolism (308) 308
heart rate - drug effects (307) 307
ligands (306) 306
antiviral agents - pharmacology (294) 294
drug interactions (289) 289
nitric oxide synthase - metabolism (289) 289
cardiac & cardiovascular systems (287) 287
molecular weight (286) 286
activation (282) 282
pharmacology (281) 281
swine (280) 280
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12132) 12132
Japanese (199) 199
German (183) 183
Russian (124) 124
French (95) 95
Italian (79) 79
Chinese (52) 52
Polish (36) 36
Spanish (32) 32
Ukrainian (11) 11
Bulgarian (6) 6
Dutch (5) 5
Portuguese (5) 5
Danish (4) 4
Romanian (4) 4
Hungarian (3) 3
Slovak (3) 3
Czech (2) 2
Serbian (2) 2
Croatian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cellular and Molecular Life Sciences, ISSN 1420-682X, 1/2014, Volume 71, Issue 2, pp. 331 - 348
Programmed necrosis is important in many (patho)physiological settings. For specific therapeutic intervention, however, a better knowledge is required whether... 
Life Sciences | Biochemistry, general | Life Sciences, general | Necroptosis | TNF | PARP-1 | Biomedicine general | Programmed necrosis | Cell Biology | APOPTOSIS | OXIDATIVE STRESS | ACTIVATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | KINASE | PARP | CELL BIOLOGY | INHIBITION | RECEPTOR-INTERACTING PROTEIN | POLYMERASE-1 | CASPASES | EXPRESSION | Free Radical Scavengers - pharmacology | Receptor-Interacting Protein Serine-Threonine Kinases - metabolism | Calpain - metabolism | Apoptosis - drug effects | Humans | Antineoplastic Agents, Alkylating - pharmacology | Guanidines - pharmacology | JNK Mitogen-Activated Protein Kinases - metabolism | Necrosis | MCF-7 Cells | RNA Interference | HEK293 Cells | Benzamides - pharmacology | Cell Line | Ceramides - metabolism | Jurkat Cells | Nuclear Pore Complex Proteins - metabolism | Piperazines - pharmacology | Poly(ADP-ribose) Polymerase Inhibitors | HT29 Cells | Phthalazines - pharmacology | Tumor Necrosis Factor-alpha - pharmacology | Poly(ADP-ribose) Polymerases - metabolism | Animals | Poly(ADP-ribose) Polymerases - genetics | Cathepsins - metabolism | Mice | HeLa Cells | Methyl Methanesulfonate - pharmacology | RNA-Binding Proteins - metabolism | RNA, Small Interfering - metabolism | Proteases | Tumor necrosis factor | Cell death | Biochemistry | Phosphotransferases | Sugars | Monosaccharides | Proteins | Gangrene | Signal transduction | Apoptosis | Index Medicus
Journal Article
Apoptosis, ISSN 1360-8185, 4/2013, Volume 18, Issue 4, pp. 393 - 408
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 2008, Volume 587, Issue 1, pp. 129 - 134
The present study was performed to examine the involvement of nitric oxide (NO) signaling pathway in the anti-convulsant effect of adenosine against... 
Sodium nitroprusside | Adenosine | L-NAME | Aminoguanidine | Pentylenetetrazol | 7-NI | Seizure threshold | Sildenafil | L-arginine | Methylene blue | pentylenetetrazol | seizure threshold | RAT | POSSIBLE INVOLVEMENT | aminoguanidine | RELEASE | FORCED SWIMMING TEST | sildenafil | GUANYLATE-CYCLASE | adenosine | methylene blue | sodium nitroprusside | CONVULSIVE BEHAVIOR | ARGININE | PHARMACOLOGY & PHARMACY | CGMP PATHWAY | BRAIN | Seizures - prevention & control | Phosphodiesterase 5 Inhibitors | Guanidines - pharmacology | Male | Nitroprusside - pharmacology | Sulfones - pharmacology | Anticonvulsants - pharmacology | Seizures - chemically induced | Cyclic AMP - physiology | Sildenafil Citrate | Cyclic Nucleotide Phosphodiesterases, Type 5 - physiology | Nitric Oxide Synthase Type II - antagonists & inhibitors | Nitric Oxide Synthase Type I - antagonists & inhibitors | Nitric Oxide Donors - pharmacology | NG-Nitroarginine Methyl Ester - pharmacology | Purines - pharmacology | Enzyme Inhibitors - pharmacology | Phosphodiesterase Inhibitors - pharmacology | Nitric Oxide - physiology | Adenosine - pharmacology | Methylene Blue - pharmacology | Piperazines - pharmacology | Indazoles - pharmacology | Animals | Signal Transduction - drug effects | Arginine - pharmacology | Convulsants | Mice | Pentylenetetrazole | Sodium nitroferricyanide | Cyanides | Seizures (Medicine) | Nitric oxide | Index Medicus
Journal Article
Neuroscience, ISSN 0306-4522, 2014, Volume 268, pp. 236 - 246
Highlights • l -NAME, aminoguanidine and sildenafil prevent LPS-induced depressive-like behavior. • l -Arginine, a NO precursor, did not prevent LPS-induced... 
Neurology | nitric oxide | depressive-like behavior | neuroinflammation | BDNF | LPS | oxidative stress | Depressive-like behavior | Oxidative stress | Neuroinflammation | Nitric oxide | ACTIVATION | GUANOSINE-MONOPHOSPHATE PATHWAY | PREPULSE INHIBITION | NITROSATIVE STRESS | MAJOR DEPRESSION | KAPPA-B | NEUROSCIENCES | L-TRYPTOPHAN | ANIMAL-MODEL | ACOUSTIC STARTLE | PITUITARY-ADRENAL AXIS | Oxidative Stress - physiology | Nitric Oxide Synthase - antagonists & inhibitors | Depressive Disorder - drug therapy | Guanidines - pharmacology | Male | Sulfones - pharmacology | Lipopolysaccharides | Brain - metabolism | Sildenafil Citrate | Interleukin-1beta - metabolism | Behavior, Animal - drug effects | Antidepressive Agents - pharmacology | Brain-Derived Neurotrophic Factor - metabolism | Disease Models, Animal | NG-Nitroarginine Methyl Ester - pharmacology | Purines - pharmacology | Enzyme Inhibitors - pharmacology | Behavior, Animal - physiology | Depressive Disorder - metabolism | Piperazines - pharmacology | Brain - drug effects | Animals | Cyclic GMP - metabolism | Signal Transduction - drug effects | Arginine - pharmacology | Depressive Disorder - prevention & control | Signal Transduction - physiology | Mice | Nitric Oxide Synthase - metabolism | Oxidative Stress - drug effects | Imipramine - pharmacology | Nitric Oxide - metabolism | Antidepressants | Mitogens | Depression, Mental | Index Medicus
Journal Article
Nephrology Dialysis Transplantation, ISSN 0931-0509, 5/2009, Volume 24, Issue 5, pp. 1429 - 1435
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 05/2012, Volume 341, Issue 2, pp. 326 - 339
Journal Article
Antiviral Research, ISSN 0166-3542, 05/2015, Volume 117, pp. 27 - 38
Journal Article
Pharmacology, Biochemistry and Behavior, ISSN 0091-3057, 06/2013, Volume 107, pp. 42 - 47
Journal Article
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2013, Volume 32, Issue 6, pp. 633 - 640
Background The cardioprotective efficacy of erythropoietin (EPO) has been widely documented in rodent models of acute coronary syndrome. We sought to evaluate... 
Surgery | heart transplantation | heart preservation | Celsior solution | glyceryl trinitrate | zoniporide | ischemia–reperfusion injury | erythropoietin | ischemia-reperfusion injury | CARDIAC & CARDIOVASCULAR SYSTEMS | REPERFUSION INJURY | CARDIAC ALLOGRAFT PRESERVATION | PROTECTS | CARIPORIDE | TRANSPLANTATION | IN-VITRO | PATHWAY | RESPIRATORY SYSTEM | ISCHEMIA/REPERFUSION | SIGNAL TRANSDUCER | Erythropoietin - pharmacology | Electrolytes - therapeutic use | Glutamates - therapeutic use | Histidine - pharmacology | Pyrazoles - therapeutic use | Rats, Wistar | Recovery of Function - drug effects | Erythropoietin - therapeutic use | Guanidines - pharmacology | Male | Cold Ischemia | Histidine - therapeutic use | Nitroglycerin - pharmacology | Mannitol - pharmacology | Dose-Response Relationship, Drug | Disaccharides - pharmacology | Heart Rate - drug effects | Glutathione - pharmacology | Myocardial Reperfusion Injury - pathology | Cardioplegic Solutions - therapeutic use | Heart Rate - physiology | Recovery of Function - physiology | Models, Animal | Disaccharides - therapeutic use | Drug Therapy, Combination | Pyrazoles - pharmacology | Glutathione - therapeutic use | Mannitol - therapeutic use | Nitroglycerin - therapeutic use | Rats | Cardioplegic Solutions - pharmacology | Treatment Outcome | Myocardial Reperfusion Injury - physiopathology | Animals | Glutamates - pharmacology | Electrolytes - pharmacology | Hypothermia - physiopathology | Guanidines - therapeutic use | Myocardial Reperfusion Injury - prevention & control | Erythropoietin | Ischemia | Coronary heart disease | Index Medicus
Journal Article